165 related articles for article (PubMed ID: 8526205)
21. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy.
Mabuchi S; Okazawa M; Kinose Y; Matsuo K; Fujiwara M; Suzuki O; Morii E; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2012 Oct; 22(8):1389-97. PubMed ID: 22976497
[TBL] [Abstract][Full Text] [Related]
23. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
[TBL] [Abstract][Full Text] [Related]
24. Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases.
Wang TY; Chen BF; Yang YC; Chen H; Wang Y; Cviko A; Quade BJ; Sun D; Yang A; McKeon FD; Crum CP
Hum Pathol; 2001 May; 32(5):479-86. PubMed ID: 11381365
[TBL] [Abstract][Full Text] [Related]
25. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy.
Harrison TA; Sevin BU; Koechli O; Nguyen HN; Averette HE; Penalver M; Donato DM; Nadji M
Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193
[TBL] [Abstract][Full Text] [Related]
26. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
27. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
28. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
29. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
[TBL] [Abstract][Full Text] [Related]
30. The significance of Erb-b2 immunostaining in cervical cancer.
Nevin J; Laing D; Kaye P; McCulloch T; Barnard R; Silcocks P; Blackett T; Paterson M; Sharp F; Cruse P
Gynecol Oncol; 1999 Jun; 73(3):354-8. PubMed ID: 10366459
[TBL] [Abstract][Full Text] [Related]
31. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
[TBL] [Abstract][Full Text] [Related]
32. ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
Braun S; Schlimok G; Heumos I; Schaller G; Riethdorf L; Riethmüller G; Pantel K
Cancer Res; 2001 Mar; 61(5):1890-5. PubMed ID: 11280743
[TBL] [Abstract][Full Text] [Related]
33. Glassy cell carcinoma of the cervix: a systematic review and meta-analysis.
Guitarte C; Alagkiozidis I; Mize B; Stevens E; Salame G; Lee YC
Gynecol Oncol; 2014 May; 133(2):186-91. PubMed ID: 24503463
[TBL] [Abstract][Full Text] [Related]
34. Glassy cell carcinoma of the uterine cervix a rare histology. Report of three cases with a review of the literature.
Deshpande AH; Kotwal MN; Bobhate SK
Indian J Cancer; 2004; 41(2):92-5. PubMed ID: 15318016
[TBL] [Abstract][Full Text] [Related]
35. The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer.
Tjalma W; Weyler J; Weyn B; Van Marck E; Van Daele A; Van Dam P; Goovaerts G; Buytaert P
Eur J Obstet Gynecol Reprod Biol; 2000 Oct; 92(2):251-7. PubMed ID: 10996690
[TBL] [Abstract][Full Text] [Related]
36. The pathology of low-grade adenosquamous carcinoma of the breast. An immunohistochemical study.
Drudis T; Arroyo C; Van Hoeven K; Cordon-Cardo C; Rosen PP
Pathol Annu; 1994; 29 ( Pt 2)():181-97. PubMed ID: 7936747
[TBL] [Abstract][Full Text] [Related]
37. [Prognosis analysis of 83 cases of cervical adenosquamous carcinoma].
Yan M; Zhang YN; He JH; Huang H
Ai Zheng; 2008 Sep; 27(9):956-61. PubMed ID: 18799035
[TBL] [Abstract][Full Text] [Related]
38. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.
Rintala M; Inki P; Klemi P; Jalkanen M; Grénman S
Gynecol Oncol; 1999 Dec; 75(3):372-8. PubMed ID: 10600292
[TBL] [Abstract][Full Text] [Related]
39. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
[TBL] [Abstract][Full Text] [Related]
40. [Clinical analysis of 21 cases of cervical adenosquamous carcinoma].
Cai HN; Wu XF; Xiang QY; Xiong YY; Zeng J
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):124-7. PubMed ID: 18683752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
